Cingulate Inc

Company Profile

Cingulate Inc had its IPO on 2021-12-08 under the ticker symbol CING.

The company operates in the Healthcare sector and Biotechnology industry. Cingulate Inc has a staff strength of 15 employees.

Stock update

Shares of Cingulate Inc opened at $1 at the start of the last trading session i.e. 2023-03-24.

The stocks traded within a range of $0.91 - $1.03, and closed at $1.03.

This is a +0.98% increase from the previous day's closing price.

A total volume of 50,273 shares were traded at the close of the day’s session.

In the last one week, shares of Cingulate Inc have increased by +8.42%.

Cingulate Inc's Key Ratios

Cingulate Inc has a market cap of $11.54 million, indicating a price to book ratio of 1.2354 and a price to sales ratio of 0.

In the last 12-months Cingulate Inc’s revenue was $0 with a gross profit of $-8995280 and an EBITDA of $-17107708. The EBITDA ratio measures Cingulate Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Cingulate Inc’s operating margin was 0% while its return on assets stood at -63.8% with a return of equity of -142.98%.

In Q4, Cingulate Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Cingulate Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-1.67 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Cingulate Inc’s profitability.

Cingulate Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -0.4476. Its price to sales ratio in the trailing 12-months stood at 0.

Cingulate Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$11.41 million

Total Liabilities

$7.01 million

Operating Cash Flow

$0

Capital Expenditure

$132630.4

Dividend Payout Ratio

0%

Cingulate Inc ended 2023 with $11.41 million in total assets and $0 in total liabilities. Its intangible assets were valued at $11.41 million while shareholder equity stood at $3.88 million.

Cingulate Inc ended 2023 with $0 in deferred long-term liabilities, $7.01 million in other current liabilities, 1131.00 in common stock, $-69408496.00 in retained earnings and $0 in goodwill. Its cash balance stood at $5.36 million and cash and short-term investments were $5.36 million. The company’s total short-term debt was $355,808 while long-term debt stood at $0.

Cingulate Inc’s total current assets stands at $7.87 million while long-term investments were $0 and short-term investments were $0.00. Its net receivables were $0 compared to accounts payable of $762357.00 and inventory worth $0.

In 2023, Cingulate Inc's operating cash flow was $0 while its capital expenditure stood at $132630.4.

Comparatively, Cingulate Inc paid $0 in dividends in 2023.

Other key metrics

Current Trading Price

$1.03

52-Week High

$2.14

52-Week Low

$0.664

Analyst Target Price

$5.88

Cingulate Inc stock is currently trading at $1.03 per share. It touched a 52-week high of $2.14 and a 52-week low of $2.14. Analysts tracking the stock have a 12-month average target price of $5.88.

Its 50-day moving average was $1.13 and 200-day moving average was $1.22 The short ratio stood at 0.51 indicating a short percent outstanding of 0%.

Around 2800.7% of the company’s stock are held by insiders while 146.9% are held by institutions.